New drug trialled in UK found to stabilise 90% of type of cancerous tumours

Researchers in the UK and US have discovered that a new experimental drug can stop the growth of and even shrink an advanced form of cancerous tumour (University Hospital Southampton/PA)

Researchers in the UK and US have discovered that a new experimental drug can stop the growth of and even shrink an advanced form of cancerous tumour.

The treatment, known as PEN-221, has been shown to stabilise neuroendocrine tumours (NETs) in almost 90% of patients and reduce the size of tumours in almost 40%.